Literature DB >> 10671546

Distinct central amphipathic alpha-helices in apolipoprotein A-I contribute to the in vivo maturation of high density lipoprotein by either activating lecithin-cholesterol acyltransferase or binding lipids.

D C McManus1, B R Scott, P G Frank, V Franklin, J R Schultz, Y L Marcel.   

Abstract

Recombinant adenoviruses with cDNAs for human apolipoprotein A-I (wild type (wt) apoA-I) and three mutants, referred to as Delta4-5A-I, Delta5-6A-I, and Delta6-7A-I, that have deletions removing regions coding for amino acids 100-143, 122-165, and 144-186, respectively, were created to study structure/function relationships of apoA-I in vivo. All mutants were expressed at lower concentrations than wt apoA-I in plasma of fasting apoA-I-deficient mice. The Delta5-6A-I mutant was found primarily in the lipid-poor high density lipoprotein (HDL) pool and at lower concentrations than Delta4-5A-I and Delta6-7A-I that formed more buoyant HDL(2/3) particles. At an elevated adenovirus dose and earlier blood sampling from fed mice, both Delta5-6A-I and Delta6-7A-I increased HDL-free cholesterol and phospholipid but not cholesteryl ester. In contrast, wt apoA-I and Delta4-5A-I produced significant increases in HDL cholesteryl ester. Further analysis showed that Delta6-7A-I and native apoA-I could bind similar amounts of phospholipid and cholesterol that were reduced slightly for Delta5-6A-I and greatly for Delta4-5A-I. We conclude from these findings that amino acids (aa) 100-143, specifically helix 4 (aa 100-121), contributes to the maturation of HDL through a role in lipid binding and that the downstream sequence (aa 144-186) centered around helix 6 (aa 144-165) is responsible for the activation of lecithin-cholesterol acyltransferase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671546     DOI: 10.1074/jbc.275.7.5043

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Structure and stability of apolipoprotein a-I in solution and in discoidal high-density lipoprotein probed by double charge ablation and deletion mutation.

Authors:  Irina N Gorshkova; Tong Liu; Horng-Yuan Kan; Angeliki Chroni; Vassilis I Zannis; David Atkinson
Journal:  Biochemistry       Date:  2006-01-31       Impact factor: 3.162

2.  The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses.

Authors:  Giorgio Cavigiolio; Baohai Shao; Ethan G Geier; Gang Ren; Jay W Heinecke; Michael N Oda
Journal:  Biochemistry       Date:  2008-03-27       Impact factor: 3.162

Review 3.  Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.

Authors:  Vassilis I Zannis; Angeliki Chroni; Monty Krieger
Journal:  J Mol Med (Berl)       Date:  2006-02-25       Impact factor: 4.599

4.  Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices.

Authors:  Mary G Sorci-Thomas; Shaila Bhat; Michael J Thomas
Journal:  Clin Lipidol       Date:  2009-02

5.  Dynamics of activation of lecithin:cholesterol acyltransferase by apolipoprotein A-I.

Authors:  Martin K Jones; Andrea Catte; Ling Li; Jere P Segrest
Journal:  Biochemistry       Date:  2009-12-01       Impact factor: 3.162

6.  Conservation of apolipoprotein A-I's central domain structural elements upon lipid association on different high-density lipoprotein subclasses.

Authors:  Michael N Oda; Madhu S Budamagunta; Ethan G Geier; Sajiv H Chandradas; Baohai Shao; Jay W Heinecke; John C Voss; Giorgio Cavigiolio
Journal:  Biochemistry       Date:  2013-09-17       Impact factor: 3.162

7.  Role of caveolin-1 in the regulation of lipoprotein metabolism.

Authors:  Philippe G Frank; Stephanos Pavlides; Michelle W-C Cheung; Kristin Daumer; Michael P Lisanti
Journal:  Am J Physiol Cell Physiol       Date:  2008-05-28       Impact factor: 4.249

8.  The carboxy-terminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo.

Authors:  Angeliki Chroni; Georgios Koukos; Adelina Duka; Vassilis I Zannis
Journal:  Biochemistry       Date:  2007-04-21       Impact factor: 3.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.